Literature DB >> 8635060

Familial cutaneous malignant melanoma and tumors of the nervous system. A hereditary cancer syndrome.

E Azizi1, J Friedman, F Pavlotsky, J Iscovich, A Bornstein, R Shafir, H Trau, H Brenner, D Nass.   

Abstract

BACKGROUND: Excessive risk of cutaneous melanoma as a second cancer has been associated with benign or malignant tumors of the nervous system. Cutaneous melanoma and nervous system tumors may independently aggregate in families. There are, however, no previous reports of increased likelihood of tumors of the nervous system in families of patients with cutaneous melanoma or--of cutaneous melanoma in families with tumors of the nervous system.
METHODS: The occurrence of nervous system tumors as second cancers was examined in a series of 904 patients with cutaneous melanoma and/or their family members.
RESULTS: Fifteen families with 17 members with cutaneous melanoma from this series had one or more additional relatives with tumors of the nervous system, including astrocytoma, medulloblastoma, glioblastoma multiforme, ependymoma, glioma, meningioma, and acoustic neurilemmoma. Another subgroup of 10 patients with cutaneous melanoma had either a meningioma (n = 9) or acoustic neurilemmoma (n = 1) as a second tumor. The pattern of atypical melanocytic nevi occurring in the majority (20/25) of cutaneous melanoma patients in our series and in additional first degree relatives of 9 of 11 of the affected families, has been previously associated with the Familial Atypical Multiple Mole-Melanoma syndrome.
CONCLUSIONS: This unusual familial and personal occurrence of tumors, showing differentiation toward tissues of the neural crest, neuroepithelium, and/or mesenchymal derivation, supports a putative association with a hereditary cancer susceptibility trait.

Entities:  

Mesh:

Year:  1995        PMID: 8635060     DOI: 10.1002/1097-0142(19951101)76:9<1571::aid-cncr2820760912>3.0.co;2-6

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  18 in total

Review 1.  Neurology and the skin.

Authors:  O Hurko; T T Provost
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-04       Impact factor: 10.154

2.  Molecular detection of tumor-associated antigens shared by human cutaneous melanomas and gliomas.

Authors:  D D Chi; R E Merchant; R Rand; A J Conrad; D Garrison; R Turner; D L Morton; D S Hoon
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

Review 3.  Hereditary melanoma: Update on syndromes and management: Genetics of familial atypical multiple mole melanoma syndrome.

Authors:  Efthymia Soura; Philip J Eliades; Kristen Shannon; Alexander J Stratigos; Hensin Tsao
Journal:  J Am Acad Dermatol       Date:  2016-03       Impact factor: 11.527

4.  Two patients with Hailey-Hailey disease, multiple primary melanomas, and other cancers.

Authors:  Melinda R Mohr; Gulsun Erdag; Amber L Shada; Michael E Williams; Craig L Slingluff; James W Patterson
Journal:  Arch Dermatol       Date:  2011-02

Review 5.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

6.  Clinical characteristics of cutaneous melanoma and second primary malignancies in a dutch hospital-based cohort of cutaneous melanoma patients.

Authors:  Haike M J van der Velden; Michelle M van Rossum; Willeke A M Blokx; Jan B M Boezeman; Marie-Jeanne P Gerritsen
Journal:  Dermatol Res Pract       Date:  2009-12-31

7.  Effect of a detailed family history of melanoma on risk for other tumors: a cohort study based on the nationwide Swedish Family-Cancer Database.

Authors:  Tianhui Chen; Mahdi Fallah; Elham Kharazmi; Jianguang Ji; Kristina Sundquist; Kari Hemminki
Journal:  J Invest Dermatol       Date:  2013-11-05       Impact factor: 8.551

Review 8.  An interstitial deletion within 9p21.3 and extending beyond CDKN2A predisposes to melanoma, neural system tumours and possible haematological malignancies.

Authors:  Maria J Baker; Alisa M Goldstein; Patricia L Gordon; Kimberly S Harbaugh; Heath B Mackley; Michael J Glantz; Joseph J Drabick
Journal:  J Med Genet       Date:  2016-01-21       Impact factor: 6.318

9.  Lack of inherited mutations of PTPRD in familial melanoma and melanoma-astrocytoma syndrome.

Authors:  David A Solomon; Jung-Sik Kim; Xiaohong R Yang; Margaret A Tucker; Alisa M Goldstein; Yardena Samuels; Todd Waldman
Journal:  Pigment Cell Melanoma Res       Date:  2009-06-03       Impact factor: 4.693

10.  Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin.

Authors:  Tadeusz Debniak
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.